Published in Ann Thorac Surg on April 01, 2007
Temporary percutaneous right ventricular support using a centrifugal pump in patients with postoperative acute refractory right ventricular failure after left ventricular assist device implantation. Eur J Cardiothorac Surg (2012) 1.18
Long graft stumps: a safe approach? Ann Thorac Surg (2007) 0.75
Tunneling a Pulmonary Artery Graft: A Simplified Way to Insert and Remove a Temporary Right Ventricular Assist Device. Tex Heart Inst J (2015) 0.75
Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med (2001) 18.91
Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med (2007) 7.15
Multicenter bridge to transplantation with the HeartMate assist device: evaluation from another perspective. A rebuttal. J Thorac Cardiovasc Surg (2003) 5.03
Sinus of Valsalva aneurysm or fistula: management and outcome. Ann Thorac Surg (1999) 4.78
Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J (2004) 3.70
Primary cardiac sarcomas. Ann Thorac Surg (1991) 3.61
Salvage of infected left ventricular assist device with antibiotic beads. Plast Reconstr Surg (2014) 3.28
Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation (2012) 3.24
Metabolic gene expression in fetal and failing human heart. Circulation (2001) 2.59
Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation (2007) 2.34
Surgical treatment of cardiac tumors: a 25-year experience. Ann Thorac Surg (1990) 2.34
Improved cardiac function with glucose-insulin-potassium after aortocoronary bypass grafting. Ann Thorac Surg (1989) 2.17
Initial clinical experience with the Jarvik 2000 implantable axial-flow left ventricular assist system. Circulation (2002) 2.15
Device-supported myocardial revascularization: safe help for sick hearts. Ann Thorac Surg (1992) 2.06
Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation (1997) 2.00
Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. Congest Heart Fail (2005) 1.99
Complete resection of a right atrial intracavitary metastatic melanoma. Ann Thorac Surg (1996) 1.95
The percutaneous ventricular assist device in severe refractory cardiogenic shock. J Am Coll Cardiol (2010) 1.94
Interrupted aortic arch in an adult single-stage extra-anatomic repair. Tex Heart Inst J (2002) 1.74
A micro-ribonucleic acid signature associated with recovery from assist device support in 2 groups of patients with severe heart failure. J Am Coll Cardiol (2011) 1.71
Coronary artery bypass for unsuccessful percutaneous transluminal coronary angioplasty. J Thorac Cardiovasc Surg (1984) 1.71
Extension of donor criteria in cardiac transplantation: surgical risk versus supply-side economics. Ann Thorac Surg (1990) 1.69
First permanent implant of the Jarvik 2000 Heart. Lancet (2000) 1.68
Transmission of retroviruses by transfusion of screened blood in patients undergoing cardiac surgery. N Engl J Med (1989) 1.67
Continuous-flow total artificial heart supports long-term survival of a calf. Tex Heart Inst J (2009) 1.64
Clinical experience with the TandemHeart percutaneous ventricular assist device. Tex Heart Inst J (2006) 1.62
End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices. J Heart Lung Transplant (2007) 1.60
Total circulatory support with an LVAD in an adolescent with a previous Fontan procedure. Tex Heart Inst J (2005) 1.58
Bacterial mediastinitis after heart transplantation. J Heart Lung Transplant (1992) 1.56
Initial experience with the AbioCor implantable replacement heart system. J Thorac Cardiovasc Surg (2004) 1.54
Clinical experience with sternotomy versus subcostal approach for exchange of the HeartMate XVE to the HeartMate II ventricular assist device. Ann Thorac Surg (2008) 1.54
Flail tricuspid leaflet after multiple biopsies following orthotopic heart transplantation: echocardiographic and hemodynamic correlation. J Heart Lung Transplant (1994) 1.52
Myocardial thievery: the coronary-subclavian steal syndrome. Ann Thorac Surg (2006) 1.52
Evaluation of myocardial function in patients with end-stage heart failure during support with the Jarvik 2000 left ventricular assist device. J Heart Lung Transplant (2005) 1.51
Advanced heart failure: feasibility study of long-term continuous axial flow pump support. Eur Heart J (2005) 1.49
Direct thrombolytic therapy for intraventricular thrombosis in patients with the Jarvik 2000 left ventricular assist device. J Heart Lung Transplant (2005) 1.48
Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. J Heart Lung Transplant (2005) 1.47
Atrial fibrillation after cardiac transplantation: experience in 498 consecutive cases. Ann Thorac Surg (2008) 1.46
Patent foramen ovale: a cause of hypoxemia in patients on left ventricular support. Ann Thorac Surg (1991) 1.45
Cardiac tumors. Clinical spectrum and prognosis of lesions other than classical benign myxoma in 20 patients. J Thorac Cardiovasc Surg (1984) 1.43
Effect of pump flow mode of novel left ventricular assist device upon end organ perfusion in dogs with doxorubicin induced heart failure. ASAIO J (2005) 1.41
First clinical use of the redesigned HeartMate II left ventricular assist system in the United States: a case report. Tex Heart Inst J (2004) 1.40
Endomyocardial nodular calcification as a cause of heart failure. Cardiovasc Pathol (2010) 1.40
Thrombogenicity of mechanical aortic valves in an animal model: site specific testing is crucial. ASAIO J (2004) 1.39
Cardiac transplantation in Puerto Rican patients at the Texas Heart Institute. Bol Asoc Med P R (1991) 1.39
TandemHeart as a rescue therapy for patients with critical aortic valve stenosis. Ann Thorac Surg (2009) 1.39
Lung cancer after heart transplantation: a 17-year experience. Ann Thorac Surg (2005) 1.39
Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device. J Heart Lung Transplant (2011) 1.38
Preclinical assessment of a trileaflet mechanical valve in the mitral position in a calf model. Ann Thorac Surg (2004) 1.38
The AbioCor implantable replacement heart. Ann Thorac Surg (2003) 1.38
Hemodynamic support with a percutaneous left ventricular assist device during stenting of an unprotected left main coronary artery. Tex Heart Inst J (2004) 1.38
Initial clinical experience of total cardiac replacement with dual HeartMate-II axial flow pumps for severe biventricular heart failure. Methodist Debakey Cardiovasc J (2011) 1.37
The use of pyloric exclusion in the management of severe duodenal injuries. Am J Surg (1977) 1.36
Downregulation of metabolic gene expression in failing human heart before and after mechanical unloading. Cardiology (2002) 1.33
Human cardiac explantation and autotransplantation: application in a patient with a large cardiac pheochromocytoma. Tex Heart Inst J (1985) 1.29
A system for grading cardiac allograft rejection. Tex Heart Inst J (1986) 1.25
Clinical experience with an implantable, intracardiac, continuous flow circulatory support device: physiologic implications and their relationship to patient selection. Ann Thorac Surg (2004) 1.24
Production and assessment of decellularized pig and human lung scaffolds. Tissue Eng Part A (2013) 1.24
Acquired commissural fusion of aortic valves in patients with left ventricular assist devices. J Heart Lung Transplant (2003) 1.22
Post-operative obesity and cachexia are risk factors for morbidity and mortality after heart transplant: multi-institutional study of post-operative weight change. J Heart Lung Transplant (2005) 1.21
Use of the Flowmaker (Jarvik 2000) left ventricular assist device for destination therapy and bridging to transplantation. Cardiology (2004) 1.20
Hemodynamics and patient safety during pump-off studies of an axial-flow left ventricular assist device. J Heart Lung Transplant (2006) 1.19
Effects of perfusion mode on regional and global organ blood flow in a neonatal piglet model. Ann Thorac Surg (1999) 1.18
Ovarian vein and caval thrombosis. Tex Heart Inst J (2005) 1.13
Pulsatile and nonpulsatile flows can be quantified in terms of energy equivalent pressure during cardiopulmonary bypass for direct comparisons. ASAIO J (2000) 1.13
Intrapericardial pheochromocytoma. Am J Med (1983) 1.13
Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support : A potential mechanism for cardiac recovery. Circulation (1999) 1.13
Monitoring regional cerebral oxygen saturation using near-infrared spectroscopy during pulsatile hypothermic cardiopulmonary bypass in a neonatal piglet model. ASAIO J (2000) 1.13
Degree of cardiac fibrosis and hypertrophy at time of implantation predicts myocardial improvement during left ventricular assist device support. J Heart Lung Transplant (2004) 1.12
Coronary artery revascularization without cardiopulmonary bypass. Tex Heart Inst J (1984) 1.11
Chronic in vivo evaluation of an electrohydraulic total artificial heart. ASAIO J (1996) 1.11
Cardiac transplantation in an 8-month-old female infant with subendocardial fibroelastosis. JAMA (1986) 1.10
Right hydrothorax after left subclavian and internal jugular vein catheterization: a delayed complication. Tex Heart Inst J (1985) 1.10
Early and late results of coronary endarterectomy. Analysis of 3,369 patients. J Thorac Cardiovasc Surg (1986) 1.09
Artificial circulatory support with textured interior surfaces. A counterintuitive approach to minimizing thromboembolism. Circulation (1994) 1.09
Surgical treatment of mitral systolic click syndrome: results in 37 patients. Ann Thorac Surg (1985) 1.08
Transmyocardial laser revascularization. Anatomic evidence of long-term channel patency. Tex Heart Inst J (1994) 1.07
Prolonged Venovenous Extracorporeal Membrane Oxygenation in a Patient With Acute Respiratory Distress Syndrome. ASAIO J (2016) 1.07
Left ventricular assist devices: an alternative to medical therapy for end-stage heart failure. Curr Opin Cardiol (2003) 1.07
Defining pulsatile perfusion: quantification in terms of energy equivalent pressure. Artif Organs (1999) 1.07
Sinus venosus atrial septal defect: early and late results following closure in 109 patients. Ann Thorac Surg (1978) 1.06
Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support. J Heart Lung Transplant (2001) 1.06
Infectious complications associated with ventricular assist systems. ASAIO J (2001) 1.06
Fibrosis and heart failure. Heart Fail Rev (2014) 1.05
Simultaneous insertion of a left ventricular assist system and repair of an ascending aortic dissection. Tex Heart Inst J (2007) 1.05
Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Follow-up results of a multicenter survey. Circulation (1991) 1.04
Congenital diverticulum of the ventricle. J Thorac Cardiovasc Surg (1986) 1.04
In vivo evaluation of the HeartWare centrifugal ventricular assist device. Tex Heart Inst J (2007) 1.04
Concomitant brachiocephalic and coronary artery disease: outcome and decision analysis. Ann Thorac Surg (2005) 1.02
Infection after cardiac transplantation: treatment and prognosis. Tex Heart Inst J (1984) 1.02